JG
FBIO icon

Jefferies Group’s Fortress Biotech FBIO Stock Holding History

Jefferies Group’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-760
Closed -$22K – 1554
2020
Q1 		$22K Buy
+760
New +$25.2K ﹤0.01% 1931
2018
Q4 		– Sell
-1,674
Closed -$40K – 2266
2018
Q3 		$40K Buy
+1,674
New +$53.6K ﹤0.01% 2290
2016
Q2 		– Sell
-693
Closed -$32K – 2220
2016
Q1 		$32K Buy
+693
New +$29.2K ﹤0.01% 2073
2014
Q3 		– Sell
-1,250
Closed -$32K – 2210
2014
Q2 		$32K Buy
+1,250
New +$33K ﹤0.01% 1954
2014
Q1 		– Sell
-17,255
Closed -$681K – 2141
2013
Q4 		$681K Buy
17,255
+16,797
+3,667% +$649K ﹤0.01% 999
2013
Q3 		$48K Sell
458
-1,967
-81% -$241K ﹤0.01% 1774
2013
Q2 		$313K Buy
+2,425
New +$358K ﹤0.01% 1299

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jefferies Group's FBIO Position: Q2 2020 in Review

Jefferies Group sold out of Fortress Biotech (FBIO) in Q2 2020, closing a stake of 760 shares — an estimated $22K sold.

Jefferies Group first reported a position in FBIO in Q2 2013 and held it in 7 quarters. The position peaked at $681K in Q4 2013. 73 funds tracked by Wall St. Rank hold FBIO as of Q2 2020.

  • Jefferies Group reported no remaining Fortress Biotech position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 760 Fortress Biotech shares in Q2 2020, an estimated $22K.
  • Jefferies Group first reported a position in Fortress Biotech in Q2 2013 and held it in 7 quarters.
  • Jefferies Group's Fortress Biotech position peaked at $681K in Q4 2013.
  • 73 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.